Medico Remedies share news, announcements and annual reports
NSE: MEDICOBSE: 540937Pharmaceuticals & BiotechnologySmall Cap
Medico Remedies Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2018 on BSE, May 2022 on NSE
Last close ₹18.61down ₹0.37 (1.95%)BSE ₹18.65
Share price at the NSE close on 30 Oct 2026. Previous close ₹18.98.
30 Oct: open ₹19.30, high ₹19.30, low ₹18.50
52-week range of traded prices to 30 Oct 2026
₹18.50Low, 30 Oct 2026₹56.88High, 24 Dec 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹154 Cr2,034th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 11.18
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.05
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 15.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.25
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,04,41886.2% delivered
Medico Remedies share news and announcements
140 announcements, routine notices left out, newest first. Page 3 of 3.
Sep 2023
6 Sep · Legal
Exchange has sought clarification from Medico Remedies Limited for the quarter ended 30-Jun-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Aug 2023
24 Aug · Meeting
10 Aug · Results
1 Aug · Board meeting
Jul 2023
21 Jul · Meeting
20 Jul · Board meeting
May 2023
11 May · Results
3 May · Board meeting
Apr 2023
Mar 2023
4 Mar · Corporate action
Feb 2023
16 Feb · Legal
Exchange has sought clarification from Medico Remedies Limited for the quarter ended 31-Dec-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not signed by authorized signatory/ies The response of the Company is awaited.10 Feb · Results
2 Feb · Meeting
2 Feb · Board meeting
2 Feb · Corporate action
2 Feb · Amendment to AOA/MOA
Jan 2023
13 Jan · Board meeting
Nov 2022
14 Nov · Related Party Transaction
Sep 2022
21 Sep · Meeting
Aug 2022
29 Aug · Meeting
16 Aug · Related Party Transaction
Jul 2022
Jun 2022
30 Jun · Results
22 Jun · Meeting